Bulent Y. Yalcin - Publications

Timing of Second-Line Nivolumab and Survival in Metastatic Renal Cell Carcinoma.

Journal: Clinical genitourinary cancer

Published: May 06, 2026

Prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer: a retrospective cohort study.

Journal: Future oncology (London, England)

Published: January 29, 2026

Prognostic ımpact of the modified Ryan tumor regression score in gastric and GEJ adenocarcinomas treated with neoadjuvant FLOT regimen.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 17, 2025

Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors-A Turkish Oncology Group Study.

Journal: Cancers

Published: December 10, 2025

Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study.

Journal: Scientific reports

Published: July 18, 2025

Synergistic prognostic effect of the renin-angiotensin-aldosterone system and immune-checkpoint inhibition in advanced lung cancer: The SPERICIL study.

Journal: International journal of cancer

Published: May 10, 2025

The effect of dose reduction of CDK4/6 inhibitors on survival in postmenopausal HR+ HER2-negative metastatic breast cancer.

Journal: Expert review of anticancer therapy

Published: April 09, 2025

CLINICAL OUTCOMES OF INTRAVENOUS GLUCOCORTICOID THERAPY WITH OR WITHOUT ORBITAL RADIOTHERAPY OR MYCOPHENOLATE MOFETIL IN ACTIVE GRAVES' ORBITOPATHY.

Journal: Acta endocrinologica (Bucharest, Romania : 2005)

Published: April 01, 2025

Enfortumab Vedotin: A Promising Therapy for Head and Neck Cancer With Potential Links to Human Papillomavirus.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 19, 2025

Comparative efficacy of adjuvant FOLFOX vs. FLOT following neoadjuvant FLOT in patients with locally advanced gastric cancer.

Journal: Turkish journal of medical sciences

Published: December 26, 2024

Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis.

Journal: Cancers

Published: December 13, 2024

Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer.

Journal: Journal of clinical medicine

Published: December 06, 2024